Fresh2 Group (NASDAQ: ANPC), formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, will be changing its ticker symbol on May 22, 2023. The company announced that its ticker symbol will change to FRES (“FRES”) at the open of market trading that day. “Transitioning to the ticker FRES is the most recent step we have taken toward our strategic initiative to focus on the recently engaged, new business line of business-to-business food trade and delivery platform for U.S. local restaurants and supermarkets,” said Fresh2 Group co-CEO Haohan Xu in the press release. “The ticker symbol change aligns with our new brand identity in the U.S. food market and reflects our vision for the future. We believe that we are well positioned to increase our presence in the new business sector with scalable business model and look forward to our future with confidence.”
To view the full press release, visit https://ibn.fm/5cGYj
About Fresh2 Group Limited
Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company is entering the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.Fresh2.co
NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
